Reference
Chin BS, et al. Similar Durability of Two Single Tablet Regimens, Dolutegravir/Abacavir/Lamivudine and Elvitegravir/Cobicistat/Tenofovir/Emtricitabine: Single Center Experience. Journal of Korean Medical Science 35: No. 29, 27 Jul 2020. Available from: URL: http://doi.org/10.3346/jkms.2020.35.e235
Rights and permissions
About this article
Cite this article
Abacavir/dolutegravir/lamivudine. Reactions Weekly 1865, 19 (2021). https://doi.org/10.1007/s40278-021-99307-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-99307-5